151 related articles for article (PubMed ID: 20919526)
1. Management of disappearing colorectal hepatic metastases.
Carpenter S; Fong Y
Adv Surg; 2010; 44():269-79. PubMed ID: 20919526
[TBL] [Abstract][Full Text] [Related]
2. Management of disappearing colorectal liver metastases.
Kuhlmann K; van Hilst J; Fisher S; Poston G
Eur J Surg Oncol; 2016 Dec; 42(12):1798-1805. PubMed ID: 27260846
[TBL] [Abstract][Full Text] [Related]
3. Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging.
Owen JW; Fowler KJ; Doyle MB; Saad NE; Linehan DC; Chapman WC
HPB (Oxford); 2016 Mar; 18(3):296-303. PubMed ID: 27017170
[TBL] [Abstract][Full Text] [Related]
4. Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases.
Lucidi V; Hendlisz A; Van Laethem JL; Donckier V
World J Gastroenterol; 2016 Apr; 22(15):3937-44. PubMed ID: 27099436
[TBL] [Abstract][Full Text] [Related]
5. Disappearing liver metastases from colorectal cancer: impact of modern imaging modalities.
Sturesson C; Nilsson J; Lindell G; Andersson RG; Keussen I
HPB (Oxford); 2015 Nov; 17(11):983-7. PubMed ID: 26252426
[TBL] [Abstract][Full Text] [Related]
6. Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect?
Gaujoux S; Goéré D; Dumont F; Souadka A; Dromain C; Ducreux M; Elias D
Dig Surg; 2011; 28(2):114-20. PubMed ID: 21540596
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography/computed tomographic scans compared to computed tomographic scans for detecting colorectal liver metastases: a systematic review.
Patel S; McCall M; Ohinmaa A; Bigam D; Dryden DM
Ann Surg; 2011 Apr; 253(4):666-71. PubMed ID: 21475005
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic parenchymal preserving liver resections for colorectal liver metastases in the era of highly effective systemic therapy and selective internal radiation therapy can often prevent a hemihepatectomy. (With video).
D'Hondt M; Ververken F; Nuytens F
Surg Oncol; 2017 Dec; 26(4):345-346. PubMed ID: 29113650
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocyte-specific MRI and contrast-enhanced intraoperative ultrasonography.
Oba A; Mise Y; Ito H; Hiratsuka M; Inoue Y; Ishizawa T; Arita J; Matsueda K; Takahashi Y; Saiura A
HPB (Oxford); 2018 Aug; 20(8):708-714. PubMed ID: 29534862
[TBL] [Abstract][Full Text] [Related]
10. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
[TBL] [Abstract][Full Text] [Related]
11. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Wiering B; Vogel WV; Ruers TJ; Oyen WJ
Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113
[TBL] [Abstract][Full Text] [Related]
12. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
[TBL] [Abstract][Full Text] [Related]
13. Optimizing resection for "responding" hepatic metastases after neoadjuvant chemotherapy.
Thomay AA; Charpentier KP
J Surg Oncol; 2010 Dec; 102(8):1002-8. PubMed ID: 20734423
[TBL] [Abstract][Full Text] [Related]
14. Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy
Vujic J; Schöllnast H; Marsoner K; Wienerroither V; Bacher H; Mischinger HJ; Kornprat P
Anticancer Res; 2019 Jul; 39(7):3847-3854. PubMed ID: 31262912
[TBL] [Abstract][Full Text] [Related]
15. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.
Wildi SM; Gubler C; Hany T; Petrowsky H; Clavien PA; Jochum W; Gerlach T; Fried M; Mullhaupt B
J Clin Ultrasound; 2008 Jan; 36(1):20-6. PubMed ID: 17937421
[TBL] [Abstract][Full Text] [Related]
17. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.
Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A
Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495
[TBL] [Abstract][Full Text] [Related]
18. Making unresectable hepatic colorectal metastases resectable--does it work?
Vauthey JN; Zorzi D; Pawlik TM
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S118-22. PubMed ID: 16399448
[TBL] [Abstract][Full Text] [Related]
19. The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer.
Rohren EM; Paulson EK; Hagge R; Wong TZ; Killius J; Clavien PA; Nelson RC
Clin Nucl Med; 2002 Aug; 27(8):550-5. PubMed ID: 12169999
[TBL] [Abstract][Full Text] [Related]
20. [Choice of surgical strategy for colorectal liver metastases depending on clinical and pathological response to neoadjuvant chemo- and targeted therapy].
Jakab F
Orv Hetil; 2010 Nov; 151(47):1956-60. PubMed ID: 21071308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
